192 related articles for article (PubMed ID: 15843588)
1. Gene expression profiling of the effect of high-dose intravenous Ig in patients with Kawasaki disease.
Abe J; Jibiki T; Noma S; Nakajima T; Saito H; Terai M
J Immunol; 2005 May; 174(9):5837-45. PubMed ID: 15843588
[TBL] [Abstract][Full Text] [Related]
2. Intravenous immunoglobulin does not increase FcgammaRIIB expression on monocytes/macrophages during acute Kawasaki disease.
Ichiyama T; Ueno Y; Hasegawa M; Ishikawa Y; Matsubara T; Furukawa S
Rheumatology (Oxford); 2005 Mar; 44(3):314-7. PubMed ID: 15572393
[TBL] [Abstract][Full Text] [Related]
3. Adrenomedullin is highly expressed in blood monocytes associated with acute Kawasaki disease: a microarray gene expression study.
Nomura I; Abe J; Noma S; Saito H; Gao B; Wheeler G; Leung DY
Pediatr Res; 2005 Jan; 57(1):49-55. PubMed ID: 15531734
[TBL] [Abstract][Full Text] [Related]
4. FCN1 (M-ficolin), which directly associates with immunoglobulin G1, is a molecular target of intravenous immunoglobulin therapy for Kawasaki disease.
Okuzaki D; Ota K; Takatsuki SI; Akiyoshi Y; Naoi K; Yabuta N; Saji T; Nojima H
Sci Rep; 2017 Sep; 7(1):11334. PubMed ID: 28900133
[TBL] [Abstract][Full Text] [Related]
5. Elevated granulocyte colony-stimulating factor levels predict treatment failure in patients with Kawasaki disease.
Abe J; Ebata R; Jibiki T; Yasukawa K; Saito H; Terai M
J Allergy Clin Immunol; 2008 Nov; 122(5):1008-1013.e8. PubMed ID: 18930517
[TBL] [Abstract][Full Text] [Related]
6. The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease.
Chang LS; Lo MH; Li SC; Yang MY; Hsieh KS; Kuo HC
Oncotarget; 2017 Jan; 8(2):2044-2052. PubMed ID: 27893416
[TBL] [Abstract][Full Text] [Related]
7. Identifying genetic hypomethylation and upregulation of Toll-like receptors in Kawasaki disease.
Huang YH; Li SC; Huang LH; Chen PC; Lin YY; Lin CC; Kuo HC
Oncotarget; 2017 Feb; 8(7):11249-11258. PubMed ID: 28061462
[TBL] [Abstract][Full Text] [Related]
8. Monocyte-Derived Interleukin-1β As the Driver of S100A12-Induced Sterile Inflammatory Activation of Human Coronary Artery Endothelial Cells: Implications for the Pathogenesis of Kawasaki Disease.
Armaroli G; Verweyen E; Pretzer C; Kessel K; Hirono K; Ichida F; Okabe M; Cabral DA; Foell D; Brown KL; Kessel C
Arthritis Rheumatol; 2019 May; 71(5):792-804. PubMed ID: 30447136
[TBL] [Abstract][Full Text] [Related]
9. Expression of FcRs on monocytes among Kawasaki disease patients with coronary artery lesions.
Xia Y; Tian X; Li Q; Wang G; Li C; Yang J
Int Immunopharmacol; 2017 Apr; 45():1-5. PubMed ID: 28147297
[TBL] [Abstract][Full Text] [Related]
10. A low-frequency IL4R locus variant in Japanese patients with intravenous immunoglobulin therapy-unresponsive Kawasaki disease.
Amano Y; Akazawa Y; Yasuda J; Yoshino K; Kojima K; Kobayashi N; Matsuzaki S; Nagasaki M; Kawai Y; Minegishi N; Ishida N; Motoki N; Hachiya A; Nakazawa Y; Yamamoto M; Koike K; Takeshita T
Pediatr Rheumatol Online J; 2019 Jul; 17(1):34. PubMed ID: 31269967
[TBL] [Abstract][Full Text] [Related]
11. The "Intermediate" CD14 + CD16 + monocyte subpopulation plays a role in IVIG responsiveness of children with Kawasaki disease.
Kim YS; Yang HJ; Kee SJ; Choi I; Ha K; Ki KK; Jeong IS; Cho HJ
Pediatr Rheumatol Online J; 2021 May; 19(1):76. PubMed ID: 34059085
[TBL] [Abstract][Full Text] [Related]
12. Intravenous immunoglobulin inhibits NF-kappaB activation and affects Fcgamma receptor expression in monocytes/macrophages.
Ichiyama T; Ueno Y; Hasegawa M; Niimi A; Matsubara T; Furukawa S
Naunyn Schmiedebergs Arch Pharmacol; 2004 Apr; 369(4):428-33. PubMed ID: 14985941
[TBL] [Abstract][Full Text] [Related]
13. Transcript abundance patterns in Kawasaki disease patients with intravenous immunoglobulin resistance.
Fury W; Tremoulet AH; Watson VE; Best BM; Shimizu C; Hamilton J; Kanegaye JT; Wei Y; Kao C; Mellis S; Lin C; Burns JC
Hum Immunol; 2010 Sep; 71(9):865-73. PubMed ID: 20600450
[TBL] [Abstract][Full Text] [Related]
14. Timing of intravenous immunoglobulin treatment and risk of coronary artery abnormalities in children with Kawasaki disease.
Bal AK; Prasad D; Umali Pamintuan MA; Mammen-Prasad E; Petrova A
Pediatr Neonatol; 2014 Oct; 55(5):387-92. PubMed ID: 24636168
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional regulation by infliximab therapy in Kawasaki disease patients with immunoglobulin resistance.
Ogihara Y; Ogata S; Nomoto K; Ebato T; Sato K; Kokubo K; Kobayashi H; Ishii M
Pediatr Res; 2014 Sep; 76(3):287-93. PubMed ID: 24964229
[TBL] [Abstract][Full Text] [Related]
16. Identification of increased expression of activating Fc receptors and novel findings regarding distinct IgE and IgM receptors in Kawasaki disease.
Chang LS; Ming-Huey Guo M; Lo MH; Kuo HC
Pediatr Res; 2021 Jan; 89(1):191-197. PubMed ID: 31816620
[TBL] [Abstract][Full Text] [Related]
17. High Dose Intravenous IgG Therapy Modulates Multiple NK Cell and T Cell Functions in Patients With Immune Dysregulation.
McAlpine SM; Roberts SE; Heath JJ; Käsermann F; Issekutz AC; Issekutz TB; Derfalvi B
Front Immunol; 2021; 12():660506. PubMed ID: 34093549
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Significance of miR-937 in Peripheral Blood Mononuclear Cells of Kawasaki Disease.
Wang Z; Zhou J; Dong N; Li W
Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710429
[TBL] [Abstract][Full Text] [Related]
19. Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.
Kitoh T; Ohara T; Muto T; Okumura A; Baba R; Koizumi Y; Yamagishi Y; Mikamo H; Daigo K; Hamakubo T
Front Immunol; 2021; 12():624802. PubMed ID: 33912155
[TBL] [Abstract][Full Text] [Related]
20. Identification of Potential Core Genes in Immunoglobulin-Resistant Kawasaki Disease Using Bioinformatics Analysis.
Pan Y; Fan Q
Crit Rev Eukaryot Gene Expr; 2020; 30(1):85-91. PubMed ID: 32421987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
